Target to Patient 2
WuXi AppTec is pleased to participate in Target to Patient 2, taking place April 20–21, 2026, in Cambridge, United Kingdom. This focused conference brings together scientists and industry professionals to explore strategies for translating early-stage discoveries into clinically relevant therapeutic candidates.
Target to Patient 2 highlights key challenges and solutions across the drug discovery and development continuum, including target validation, candidate optimization, translational pharmacology, and approaches to improve the likelihood of clinical success. Through expert presentations and collaborative discussions, the event provides valuable insights into bridging the gap between research and patient outcomes.
At WuXi AppTec, we support partners with integrated discovery, development, and manufacturing services that enable efficient progression from early research to clinical stages. Our capabilities span medicinal chemistry, biology, DMPK, pharmacology, preclinical development, and CMC services, helping to advance programs with quality, reliability, and speed.
We look forward to connecting in Cambridge and discussing how WuXi AppTec can support your journey from target to patient.
To schedule a dedicated meeting with our team, please fill out the form on the right.
Resource Links
WuXi AppTec Biology Services
Resource Type: Brochure
